Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-010222
Filing Date
2018-08-01
Accepted
2018-08-01 17:15:50
Documents
68
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lnth10q-063018.htm 10-Q 1061143
2 EXHIBIT 31.1 lnth10q-063018ex311.htm EX-31.1 14939
3 EXHIBIT 31.2 lnth10q-063018ex312.htm EX-31.2 15008
4 EXHIBIT 32.1 lnth10q-063018ex321.htm EX-32.1 13761
  Complete submission text file 0001628280-18-010222.txt   4445117

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lnth-20180630.xml EX-101.INS 849430
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20180630.xsd EX-101.SCH 38097
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20180630_cal.xml EX-101.CAL 74724
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20180630_def.xml EX-101.DEF 117151
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20180630_lab.xml EX-101.LAB 408539
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20180630_pre.xml EX-101.PRE 240148
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 18985756
SIC: 2835 In Vitro & In Vivo Diagnostic Substances